Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-29

Clinical Trial Update: Prospective Observational Association Between SLCO1B1 Gene Polymorphism and the Anti-factor Xa Activity of Edoxaban in Patients With Moderate to Severe Renal Insufficiency

View source ↗

Summary

This prospective observational study investigates whether SLCO1B1 gene polymorphism influences the anti-factor Xa activity of edoxaban in patients with moderate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Savaysa (edoxaban)

Snippet

Sponsor: Yi Han | Conditions: Gene Polymorphism, Edoxaban | Status: RECRUITING